Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
European Journal of Clinical Pharmacology
|
January 1, 1990
Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans
K Mross, U Mayer, K Hamm, et al.
Cancer Treatment Reviews
|
November 2, 1999
Current options in treatment of anthracycline-resistant breast cancer
N Kröger, W Achterrath, S Hegewisch-Becker, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Tissue disposition and plasma concentrations of idarubicin after intravesical therapy in patients with bladder tumors
K Mross, K Hamm, W Schultze-Seemann, et al.
British Journal of Cancer
|
May 6, 1998
Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
M Lehnert, K Mross, J Schueller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Toxicity, pharmacokinetics and metabolism of iododoxorubicin in cancer patients
K Mross, U Mayer, T Langenbuch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1994
Pharmacokinetics of undiluted or diluted high-dose etoposide with or without busulfan administered to patients with hematologic malignancies
K Mross, P Bewermeier, W Krüger, et al.
Arzneimittel-Forschung
|
January 15, 2000
Phase II study with 5-fluorouracil and ginkgo biloba extract (GBE 761 ONC) in patients with pancreatic cancer
B Hauns, B Häring, S Köhler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1996
The pharmacokinetics and toxicity of two application schedules with high-dose VP-16 in patients receiving an allogeneic bone marrow transplantation
K Mross, J Reifke, P Bewermeier, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie
|
December 1, 1986
Enolase isoenzymes as tumour markers
K D Gerbitz, J Summer, I Schumacher, et al.
Onkologie
|
February 5, 2003
Comparison of 1-hour and 3-hours paclitaxel infusion pharmacokinetics: results from a randomized trial
K Mross, B Häring, N Holländer, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
European Journal of Clinical Pharmacology
|
January 1, 1990
Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans
K Mross, U Mayer, K Hamm, et al.
Cancer Treatment Reviews
|
November 2, 1999
Current options in treatment of anthracycline-resistant breast cancer
N Kröger, W Achterrath, S Hegewisch-Becker, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Tissue disposition and plasma concentrations of idarubicin after intravesical therapy in patients with bladder tumors
K Mross, K Hamm, W Schultze-Seemann, et al.
British Journal of Cancer
|
May 6, 1998
Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
M Lehnert, K Mross, J Schueller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Toxicity, pharmacokinetics and metabolism of iododoxorubicin in cancer patients
K Mross, U Mayer, T Langenbuch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1994
Pharmacokinetics of undiluted or diluted high-dose etoposide with or without busulfan administered to patients with hematologic malignancies
K Mross, P Bewermeier, W Krüger, et al.
Arzneimittel-Forschung
|
January 15, 2000
Phase II study with 5-fluorouracil and ginkgo biloba extract (GBE 761 ONC) in patients with pancreatic cancer
B Hauns, B Häring, S Köhler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1996
The pharmacokinetics and toxicity of two application schedules with high-dose VP-16 in patients receiving an allogeneic bone marrow transplantation
K Mross, J Reifke, P Bewermeier, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie
|
December 1, 1986
Enolase isoenzymes as tumour markers
K D Gerbitz, J Summer, I Schumacher, et al.
Onkologie
|
February 5, 2003
Comparison of 1-hour and 3-hours paclitaxel infusion pharmacokinetics: results from a randomized trial
K Mross, B Häring, N Holländer, et al.
Page
of 7